Biotechnology Assets SA
MAD:BST

Watchlist Manager
Biotechnology Assets SA Logo
Biotechnology Assets SA
MAD:BST
Watchlist
Price: 0.29 EUR -0.68%
Market Cap: 18.9m EUR
Have any thoughts about
Biotechnology Assets SA?
Write Note

Biotechnology Assets SA
Interest Income Expense

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Biotechnology Assets SA
Interest Income Expense Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Interest Income Expense CAGR 3Y CAGR 5Y CAGR 10Y
Biotechnology Assets SA
MAD:BST
Interest Income Expense
-€314.8k
CAGR 3-Years
21%
CAGR 5-Years
29%
CAGR 10-Years
N/A
Grifols SA
MAD:GRF
Interest Income Expense
-€332.3m
CAGR 3-Years
-68%
CAGR 5-Years
-4%
CAGR 10-Years
N/A
Oryzon Genomics SA
MAD:ORY
Interest Income Expense
-€1.6m
CAGR 3-Years
-48%
CAGR 5-Years
-14%
CAGR 10-Years
N/A
Pharma Mar SA
MAD:PHM
Interest Income Expense
-€490k
CAGR 3-Years
43%
CAGR 5-Years
34%
CAGR 10-Years
21%
No Stocks Found

Biotechnology Assets SA
Glance View

Market Cap
18.5m EUR
Industry
Biotechnology

Biotechnology Assets SA operates as a biopharmaceutical company. The company is headquartered in Jerez De La Frontera, Cadiz and currently employs 32 full-time employees. The company went IPO on 2011-06-14. The Firm’s main activities are: Research, development and production of biotechnological solutions aimed at improving the health and welfare of people and animals; Development, acquisition, transfer and exploitation of industrial and intellectual property rights; Distribution, marketing, export and import of the previously mentioned products. The Company, through its subsidiaries, is also present in Luxembourg, Hong Kong and USA.

BST Intrinsic Value
0.29 EUR
Overvaluation 1%
Intrinsic Value
Price

See Also

What is Biotechnology Assets SA's Interest Income Expense?
Interest Income Expense
-314.8k EUR

Based on the financial report for Jun 30, 2024, Biotechnology Assets SA's Interest Income Expense amounts to -314.8k EUR.

What is Biotechnology Assets SA's Interest Income Expense growth rate?
Interest Income Expense CAGR 5Y
29%

Over the last year, the Interest Income Expense growth was -22%. The average annual Interest Income Expense growth rates for Biotechnology Assets SA have been 21% over the past three years , 29% over the past five years .

Back to Top